| 注册
首页|期刊导航|临床肝胆病杂志|半乳糖凝集素-9(Gal-9)介导的免疫调节作用在肝脏疾病中的研究进展

半乳糖凝集素-9(Gal-9)介导的免疫调节作用在肝脏疾病中的研究进展

凌珺 朱冰 陈威巍 王卓然 余丽梅 游绍莉

临床肝胆病杂志2024,Vol.40Issue(1):193-198,6.
临床肝胆病杂志2024,Vol.40Issue(1):193-198,6.DOI:10.12449/JCH240132

半乳糖凝集素-9(Gal-9)介导的免疫调节作用在肝脏疾病中的研究进展

Research advances in the immunomodulatory mechanism of galectin-9 and its role in liver diseases

凌珺 1朱冰 2陈威巍 2王卓然 2余丽梅 3游绍莉2

作者信息

  • 1. 遵义医科大学附属医院贵州省细胞工程重点实验室,贵州 遵义 563003||中国人民解放军总医院第五医学中心肝病医学部,北京 100039
  • 2. 中国人民解放军总医院第五医学中心肝病医学部,北京 100039
  • 3. 遵义医科大学附属医院贵州省细胞工程重点实验室,贵州 遵义 563003
  • 折叠

摘要

Abstract

Galectin-9(Gal-9)is a member of the galectin family that can specifically recognize and bind to galactosides.Recent studies have shown that Gal-9 is highly expressed in the liver and can help to maintain intrahepatic immune homeostasis and perform biological functions in various liver diseases.This article reviews the immunomodulatory functions of Gal-9 and its role in different liver diseases.Studies have shown that Gal-9 has important biological functions in different liver diseases through multiple pathways.Research on the specific immunomodulatory mechanisms and functions of Gal-9 may help to discover the therapeutic role of Gal-9 in liver diseases.

关键词

半乳糖凝集素-9/免疫调节/肝脏疾病

Key words

Galectin-9/Immunomodulation/Liver Diseases

引用本文复制引用

凌珺,朱冰,陈威巍,王卓然,余丽梅,游绍莉..半乳糖凝集素-9(Gal-9)介导的免疫调节作用在肝脏疾病中的研究进展[J].临床肝胆病杂志,2024,40(1):193-198,6.

基金项目

国家科技重大专项资助(2017ZX10203201) (2017ZX10203201)

国家重点研发计划资助(2021YFC2301801) National Science and Technology Major Project(2017ZX10203201) (2021YFC2301801)

Funded Projects of National Key R&D Program(2021YFC2301801) (2021YFC2301801)

临床肝胆病杂志

OA北大核心CSTPCD

1001-5256

访问量5
|
下载量0
段落导航相关论文